BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 6572933)

  • 21. Expression of C3b receptors on human be cells and myelomonocytic cells but not natural killer cells.
    Tedder TF; Fearon DT; Gartland GL; Cooper MD
    J Immunol; 1983 Apr; 130(4):1668-73. PubMed ID: 6220062
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.
    Brown EJ; Ramsey J; Hammer CH; Frank MM
    J Immunol; 1983 Jul; 131(1):403-8. PubMed ID: 6602833
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enzymic assay of C3b receptor on intact cells and solubilized cells.
    Sim E; Sim RB
    Biochem J; 1983 Feb; 210(2):567-76. PubMed ID: 6222733
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Erythrocyte complement receptor (C3b) expression in multiple sclerosis].
    Nowak J; Wender M
    Neurol Neurochir Pol; 1990; 24(5-6):277-85. PubMed ID: 2131424
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polymorphism in the Mr 32,000 Rh protein purified from Rh(D)-positive and -negative erythrocytes.
    Saboori AM; Smith BL; Agre P
    Proc Natl Acad Sci U S A; 1988 Jun; 85(11):4042-5. PubMed ID: 3131772
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Physiologic inactivation of fluid phase C3b: isolation and structural analysis of C3c, C3d,g (alpha 2D), and C3g.
    Davis AE; Harrison RA; Lachmann PJ
    J Immunol; 1984 Apr; 132(4):1960-6. PubMed ID: 6607952
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased efficiency of binding of nascent C3b to the erythrocytes of chronic cold agglutinin disease.
    Parker CJ; Soldato CM; Telen MJ
    J Clin Invest; 1984 Sep; 74(3):1050-62. PubMed ID: 6236231
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structural heterogeneity of the C3b/C4b receptor (Cr 1) on human peripheral blood cells.
    Dykman TR; Cole JL; Iida K; Atkinson JP
    J Exp Med; 1983 Jun; 157(6):2160-5. PubMed ID: 6222138
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Herpes simplex virus type 1 infection of endothelial, epithelial, and fibroblast cells induces a receptor for C3b.
    Smiley ML; Hoxie JA; Friedman HM
    J Immunol; 1985 Apr; 134(4):2673-8. PubMed ID: 2982950
    [TBL] [Abstract][Full Text] [Related]  

  • 30. C4 receptors in the human glomeruli.
    Matre R; Tönder O
    Int Arch Allergy Appl Immunol; 1980; 63(3):312-6. PubMed ID: 7419292
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Deficiency of an erythrocyte membrane protein with complement regulatory activity in paroxysmal nocturnal hemoglobinuria.
    Pangburn MK; Schreiber RD; Müller-Eberhard HJ
    Proc Natl Acad Sci U S A; 1983 Sep; 80(17):5430-4. PubMed ID: 6225118
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Abnormality of glycophorin-alpha on paroxysmal nocturnal hemoglobinuria erythrocytes.
    Parker CJ; Soldato CM; Rosse WF
    J Clin Invest; 1984 Apr; 73(4):1130-43. PubMed ID: 6231312
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of surface proteins and glycoproteins on red blood cells from mice infected with haemosporidia: Babesia rodhaini infections of BALB/c mice.
    Howard RJ; Smith PM; Mitchell GF
    Parasitology; 1980 Oct; 81(2):251-71. PubMed ID: 7443293
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of a partial cDNA clone for the C3d/Epstein-Barr virus receptor of human B lymphocytes: homology with the receptor for fragments C3b and C4b of the third and fourth components of complement.
    Weis JJ; Fearon DT; Klickstein LB; Wong WW; Richards SA; de Bruyn Kops A; Smith JA; Weis JH
    Proc Natl Acad Sci U S A; 1986 Aug; 83(15):5639-43. PubMed ID: 3016712
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characteristics of isolated erythrocyte complement receptor type one (CR1, C4b-C3b receptor) and CR1-specific antibodies.
    Dobson NJ; Lambris JD; Ross GD
    J Immunol; 1981 Feb; 126(2):693-8. PubMed ID: 7005341
    [No Abstract]   [Full Text] [Related]  

  • 36. Characterization of a monoclonal antibody against P57, the C3/C3b-cleaving proteinase expressed in human erythrocyte membranes.
    Fiandino-Tirel A; Barel M; Lyamani F; Gauffre A; Hermann J; Frade R
    Hybridoma; 1991 Aug; 10(4):449-58. PubMed ID: 1937496
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interaction between the labile binding sites of the fourth (C4) and fifth (C5) human complement proteins and erythrocyte cell membranes.
    Law SK; Lichtenberg NA; Holcombe FH; Levine RP
    J Immunol; 1980 Aug; 125(2):634-9. PubMed ID: 7391573
    [TBL] [Abstract][Full Text] [Related]  

  • 38. C3 receptors on human lymphocyte subsets and recruitment of ADCC effector cells by C3 fragments.
    Wåhlin B; Perlmann H; Perlmann P; Schreiber RD; Müller-Eberhard HJ
    J Immunol; 1983 Jun; 130(6):2831-6. PubMed ID: 6222118
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of human factor I and C3b receptor in the cleavage of surface-bound C3bi molecules.
    Medicus RG; Melamed J; Arnaout MA
    Eur J Immunol; 1983 Jun; 13(6):465-70. PubMed ID: 6222909
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of a soluble form of the C3b/C4b receptor (CR1) in human plasma.
    Yoon SH; Fearon DT
    J Immunol; 1985 May; 134(5):3332-8. PubMed ID: 3156931
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.